Ascendis Pharma A/S Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities
Ascendis Pharma A/S (ASND) reported Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities of EUR 131.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities · last filed 2026-02-11
- Ascendis Pharma A/S adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2025-12-31 was 1.22M EUR.
- Ascendis Pharma A/S adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2025-09-30 was 2.37M EUR, a 709.22% increase year-over-year.
- Ascendis Pharma A/S adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2025-06-30 was 599.00K EUR, a 444.55% increase year-over-year.
- Ascendis Pharma A/S adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2025-03-31 was -4.05M EUR.
| Period end | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 3 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 6 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 9 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.22M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 3.59M EUR derived: sum of 2 quarters · filed 2026-02-11 | 4.18M EUR derived: sum of 3 quarters · filed 2026-02-11 | 131.00K EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 2.37M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 2.97M EUR derived: sum of 2 quarters · filed 2025-11-12 | -1.08M EUR 6-K · filed 2025-11-12 | -1.73M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 599.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | -3.46M EUR 6-K · filed 2025-08-07 | -4.11M EUR derived: sum of 3 quarters · filed 2026-02-11 | -3.81M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | -4.05M EUR 6-K · filed 2025-05-01 | -4.70M EUR derived: sum of 2 quarters · filed 2026-02-11 | -4.41M EUR derived: sum of 3 quarters · filed 2026-02-11 | -4.30M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | -650.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -357.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | -247.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | -1.20M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 293.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 403.00K EUR derived: sum of 2 quarters · filed 2025-11-12 | -547.00K EUR 6-K · filed 2025-11-12 | 1.61M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 110.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | -840.00K EUR 6-K · filed 2025-08-07 | 1.31M EUR derived: sum of 3 quarters · filed 2026-02-11 | 1.20M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -950.00K EUR 6-K · filed 2025-05-01 | 1.20M EUR derived: sum of 2 quarters · filed 2026-02-11 | 1.09M EUR derived: sum of 3 quarters · filed 2026-02-11 | -7.77M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 2.15M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 2.04M EUR derived: sum of 2 quarters · filed 2026-02-11 | -6.82M EUR derived: sum of 3 quarters · filed 2026-02-11 | -7.08M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | -115.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | -8.98M EUR derived: sum of 2 quarters · filed 2024-11-14 | -9.23M EUR 6-K · filed 2024-11-14 | -11.31M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -8.86M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | -9.12M EUR 6-K · filed 2024-09-03 | -11.20M EUR derived: sum of 3 quarters · filed 2025-02-12 | 1.40M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -256.00K EUR 6-K · filed 2024-05-02 | -2.33M EUR derived: sum of 2 quarters · filed 2025-02-12 | 10.26M EUR derived: sum of 3 quarters · filed 2025-02-12 | 10.73M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -2.08M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 10.51M EUR derived: sum of 2 quarters · filed 2025-02-12 | 10.99M EUR derived: sum of 3 quarters · filed 2025-02-12 | 8.65M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 12.59M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 13.06M EUR derived: sum of 2 quarters · filed 2023-11-07 | 10.73M EUR 6-K · filed 2023-11-07 | |
| 2022-06-30 | 473.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | -1.86M EUR 6-K · filed 2023-09-05 | ||
| 2022-03-31 | -2.34M EUR 6-K · filed 2023-04-27 | |||
| 2021-12-31 | 5.20M EUR 20-F · filed 2024-02-07 |